NCT01846091View on ClinicalTrials.gov

Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 9, 2013

Primary Completion Date

September 18, 2019

Study Completion Date

November 26, 2019

Conditions
Estrogen Receptor NegativeEstrogen Receptor PositiveHead and Neck Squamous Cell CarcinomaHER2/Neu NegativeHER2/Neu PositiveInvasive Breast CarcinomaProgesterone Receptor NegativeProgesterone Receptor PositiveRecurrent Head and Neck CarcinomaStage IV Breast CancerTriple-Negative Breast Carcinoma
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter

Given IT

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER